Safety of Intravenous Iron in CKD Stage 3-5 Patients Not on Dialysis: A Retrospective Cohort Study

Safety of Intravenous Iron in CKD Stage 3-5 Patients Not on Dialysis: A Retrospective Cohort Study

Background: Iron deficiency is common in chronic kidney disease (CKD) patients not on dialysis (ND). Restoring depleted iron stores through intravenous (IV) route is faster and associated with less side effects. There is conflicting data regarding intravenous iron use and its impact on clinical outc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Canadian journal of kidney health and disease 2022, Vol.9, p.20543581221130685-20543581221130685
Hauptverfasser: AlSahow, Ali, AlYousef, Anas, Nawar, Hani, AlHelal, Bassam, AlQallaf, Ahmed, AlMuhaiteeb, Abdullah, ElSharkawi, Yasser, AlRajab, Heba, Ali, Hamad, Kumar, Rajeev
Format: Artikel
Sprache:eng
Schlagworte:
Cohort analysis
Hemodialysis
Hemoglobin
Hospitalization
Iron
Original
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: Iron deficiency is common in chronic kidney disease (CKD) patients not on dialysis (ND). Restoring depleted iron stores through intravenous (IV) route is faster and associated with less side effects. There is conflicting data regarding intravenous iron use and its impact on clinical outcomes in this population. Objective: This study aims at evaluating any negative clinical impact associated with IV iron use in CKD patients at stages (3-5) before dialysis. Design: Retrospective chart review. Setting and Population: Chart analysis of ND CKD 3-5 (estimated glomerular filtration rate [eGFR]
ISSN:2054-3581
2054-3581
DOI:10.1177/20543581221130685